BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 322258)

  • 1. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
    Bendtzen K
    Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
    Bendtzen K
    Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated cytotoxicity in humans. III. Effect of protease inhibitors and substrates.
    Trinchieri G; De Marchi M
    J Immunol; 1976 Apr; 116(4):885-91. PubMed ID: 1254969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines.
    Poste G
    Cancer Res; 1975 Sep; 35(9):2558-66. PubMed ID: 167963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The requirement for esterase activation in T cell replacing factor (TRF)-induced IgG production in a human B blastoid cell line.
    Miki Y; Kishi H; Muraguchi A; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1982 Feb; 128(2):675-8. PubMed ID: 6798119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enhancement of MIF activity by inhibition of macrophage associated esterases.
    Remold HG
    J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical and functional properties of serine esterases in acidic cytoplasmic granules of cytotoxic T lymphocytes.
    Henkart PA; Berrebi GA; Takayama H; Munger WE; Sitkovsky MV
    J Immunol; 1987 Oct; 139(7):2398-405. PubMed ID: 3498759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of an activatable esterase in immune-dependent phagocytosis by human neutrophils.
    Musson RA; Becker EL
    J Immunol; 1977 Apr; 118(4):1354-65. PubMed ID: 850067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
    Bendtzen K
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells.
    Kramer MD; Binninger L; Schirrmacher V; Moll H; Prester M; Nerz G; Simon MM
    J Immunol; 1986 Jun; 136(12):4644-51. PubMed ID: 2423597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system.
    Forney JR; Yang S; Du C; Healey MC
    J Parasitol; 1996 Aug; 82(4):638-40. PubMed ID: 8691375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that human leukocyte inhibitory factor (LIF) is an esterase.
    Rocklin RE; Rosenthal AS
    J Immunol; 1977 Jul; 119(1):249-52. PubMed ID: 326958
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of the activity of human serum cholinesterase by aminoalkyl benzenesulfonyl fluorides].
    Kleking GP; Markvardt F; Rikhter M
    Farmakol Toksikol; 1976; 39(3):265-8. PubMed ID: 1026506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine effect upon the erythrocyte antibody uptake by human monocytes.
    Sipka S; Kávai M; Teichmann F; Boldogh I; Szegedi G
    Haematologia (Budap); 1987; 20(2):73-8. PubMed ID: 3115874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.